Apo-Pharma Inc.

Canada · Reporting entity ID 100000010622

Total reported 2019–2025

$139K

#2,036 of 2,960 reporting companies — 0% of all reported industry payments

$21K in general payments across 17 records, plus $118K in research funding across 23 records.

How it breaks down

General payments $21,334

Research funding $117,918

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.